Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. Shohet
Pcn42 - Efficacy of Third Line Tyrosine Kinase Inhibitors for Treatment of Advanced Gastrointestinal Stromal Tumours: Systematic Review and Meta-Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Complementary Activity of Tyrosine Kinase Inhibitors Against Secondary Kit Mutations in Imatinib-Resistant Gastrointestinal Stromal Tumours
British Journal of Cancer
Cancer Research
Oncology
Correction: Complementary Activity of Tyrosine Kinase Inhibitors Against Secondary Kit Mutations in Imatinib-Resistant Gastrointestinal Stromal Tumours
British Journal of Cancer
Cancer Research
Oncology
Systematic Review and Meta-Analysis: Efficacy and Safety of Oral Janus Kinase Inhibitors for Inflammatory Bowel Disease
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Efficacy and Safety of Angiogenesis Inhibitors in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Meta-Analysis of EGFR Tyrosine Kinase Inhibitors Compared With Chemotherapy as Second-Line Treatment in Pretreated Advanced Non-Small Cell Lung Cancer
PLoS ONE
Multidisciplinary
Imatinib for the Treatment of Patients With Unresectable and/or Metastatic Gastrointestinal Stromal Tumours: Systematic Review and Economic Evaluation
Health Technology Assessment
Medicine
Health Policy
Impact of Patient’s Age on Efficacy of Immune Checkpoint Inhibitors in Advanced Cancers: A Systematic Review and Meta-Analysis
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Practical Role of Mutation Analysis for Imatinib Treatment in Patients With Advanced Gastrointestinal Stromal Tumors: A Meta-Analysis
PLoS ONE
Multidisciplinary
Economic Evaluation of First Line Treatment for Advanced Non Small Cell Lung Cancer Using Tyrosine Kinase Inhibitors in Malaysia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
